Is OLYS Pharma still active?

Yes, OLYS Pharma is currently active.

What does OLYS Pharma do?

OLYS Pharma's registered main activities are Manufacture of medicaments and Research and experimental development on other natural sciences and engineering.

Where is OLYS Pharma registered?

OLYS Pharma's registered address is Avenue Wolfers 32, 1310 La Hulpe, Belgium.

Did OLYS Pharma make a profit or a loss?

OLYS Pharma's most recently filed annual accounts (fiscal year ending 31 Dec 2024) reported a profit of €533,570.

When did OLYS Pharma last file annual accounts?

OLYS Pharma's most recently filed annual accounts cover the fiscal year ending 31 Dec 2024.

Is OLYS Pharma B Corp certified?

We have no B Corp certification on file for OLYS Pharma.

Does OLYS Pharma hold Fairtrade certification?

No, OLYS Pharma does not currently hold Fairtrade certification.

OLYS Pharma

Q: When was OLYS Pharma founded?

OLYS Pharma was founded on 25 Sep 2020, making it 5 years old.

BE 0754.895.372

Copied!

BV/SRL

Status

Active

Founded

25 Sep 2020

Size

Micro

Age

5 yrs

Main activity

Manufacture of medicaments

Website

olyspharma.com

Activities

2 activities

Manufacture of medicamentsResearch and experimental development on other natural sciences and engineering

Financials

Profit / Loss2024

€534K+381%

Equity2024

€565K+394.6%

Cash2024

€167K>1000%

2024	2023	2022	2021
€533,570+381%	-€189,895+14.1%	-€220,969+3.2%	-€228,239
€564,848+394.6%	-€191,722<-1000%	-€1,827-100.7%	€267,818
€467,901-6.8%	€502,287+69.9%	€295,711+9.4%	€270,209
€166,591>1000%	€902-93.5%	€13,844-96.5%	€399,591

Frequently asked questions

01What is OLYS Pharma's official registered name?

OLYS Pharma.

02What is OLYS Pharma's enterprise number (VAT number)?

BE 0754.895.372.

03What is OLYS Pharma's legal form?

Besloten Vennootschap (BV) / Société à responsabilité limitée (SRL).

04When was OLYS Pharma founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2024	2023	2022	2021
Income statement
	€634,961+898.7%	-€79,500+54.9%	-€176,316+35.1%	-€271,664
	-€20-100%	€36,475-28.2%	€50,812	—
	—	—	€1,566	—
	€545,072+387.8%	-€189,385+31.4%	-€275,870+2.9%	-€284,035
	€533,570+381%	-€189,895+14.1%	-€220,969+3.2%	-€228,239
	€17	—	€2,618	—
Profitability
	94.5%-4.6%	99.0%-99.2%	12093.1%>1000%	-85.2%
	51.7%+184.5%	-61.1%+18.7%	-75.2%-77.2%	-42.4%
Solvency
	€1,032,748+232.5%	€310,565+5.7%	€293,883-45.4%	€538,026
	€408-56.1%	€930-36%	€1,452	—
	€564,848+394.6%	-€191,722<-1000%	-€1,827-100.7%	€267,818
	54.7%+188.6%	-61.7%<-1000%	-0.6%-101.2%	49.8%
	€200,0000%	€200,0000%	€200,000-20%	€250,000
	0.35+133.9%	-1.04+99.1%	-109.46<-1000%	0.93
	€467,901-6.8%	€502,287+69.9%	€295,711+9.4%	€270,209
	0.83+131.6%	-2.62+98.4%	-161.84<-1000%	1.01
Liquidity
	€166,591>1000%	€902-93.5%	€13,844-96.5%	€399,591
	€7,1950%	€7,195-55.2%	€16,046-21%	€20,301
	€2,876+24.6%	€2,309-91.3%	€26,446	—
	€16,632-78.4%	€76,991+20.8%	€63,746+216.9%	€20,119
	€267,901-11.4%	€302,287+215.8%	€95,711+373.6%	€20,209
	0.10+114.7%	0.04-90%	0.45-70.6%	1.53
	-€75,648+73.7%	-€287,896-639.1%	-€38,951-109.5%	€410,206
Profit appropriation
	-€105,533+83.5%	-€639,102-42.3%	-€449,208-96.8%	-€228,239